References
- Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006;368:404-418. https://doi.org/10.1016/S0140-6736(06)69114-9
- Cooper DS. Antithyroid drugs. N Engl J Med 1984;311:1353-1362. https://doi.org/10.1056/NEJM198411223112106
- Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998;27:109-126. https://doi.org/10.1016/S0889-8529(05)70302-9
- Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 1992;102:1595-1596. https://doi.org/10.1378/chest.102.5.1595
- Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993;342:651-652. https://doi.org/10.1016/0140-6736(93)91761-A
- Kang AY, Baek YH, Sohn YJ, et al. Diffuse alveolar hemorrhage associated with antineutrophil cytoplasmic antibody levels in a pregnant woman taking propylthiouracil. Korean J Intern Med 2006;21:240-243. https://doi.org/10.3904/kjim.2006.21.4.240
- Chen YX, Yu HJ, Li LY, et al. Propylthiouracil-associated antineutrophil cytoplasmic autoan tibody-positive vasculitis: retrospective study of 19 cases. J Rheumatol 2007;34:2451-2456.
- Yu F, Chen M, Gao Y, et al. Clinical and pat hological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis 2007;49:607-614. https://doi.org/10.1053/j.ajkd.2007.01.021
- Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Endocr J 2002;49:329-334. https://doi.org/10.1507/endocrj.49.329
- Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S. Prevalence and clinical significance of antineutrophjl cytoplasmic antibody in Graves' patients treated with propylthiouracil. Int J Clin Pract 2009;63:299-302. https://doi.org/10.1111/j.1742-1241.2006.01250.x
- Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994;266:810-813. https://doi.org/10.1126/science.7973636
- Von Schmiedeberg S, Goebel C, Gleichmann E, Uetrecht J. Neutrophils and drug metabolism. Science 1995;268:585-586.
- Shimizudani N, Senba S, Odaka T, et al. A case of MPO-ANCA positive vasculitis associated with multiple pulmonary nodules following propylthiouracil treatment. Nihon Kokyuki Gakkai Zasshi 2009;47:98-103.
- Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-784. https://doi.org/10.1016/S0272-6386(03)00025-8
- Winters MJ, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol 2002;17:257-260. https://doi.org/10.1007/s00467-001-0807-9
- Grcevska L, Polenakovic M, Petrusevska G. Membranous nephropathy associated with thyroid disorders. Nephron 2000;86:534-535. https://doi.org/10.1159/000045857
- Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev 1984;5:309-355. https://doi.org/10.1210/edrv-5-2-309
- Kim HJ, Baek JE, Ha HJ, et al. A case of membranous nephropathy in a patient with Graves' disease. Korean J Med 2003;64:130-136.